mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.05 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.05 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |